Original study
Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease

https://doi.org/10.1016/S0167-5273(96)02779-9Get rights and content

Abstract

We investigated the association of paraoxonase (PON) gene polymorphism with both the occurrence of coronary heart disease (CHD) and the severity of coronary artery stenosis in Japanese subjects. PON is a protein associated with plasma HDL. It has been hypothesized an A/B (Gln 192 → Arg) polymorphism of PON may be involved in the pathogenesis of CHD, especially among subjects with non-insulin-dependent diabetes mellitus (NIDDM). The polymorphism was determined in 134 patients with myocardial infarction (MI) or angina pectoris, and in 252 healthy subjects as controls. The frequencies of the AA, AB, and BB genotypes in the patients were 15, 50, and 35%, respectively, and these frequencies did not differ from those in control subjects (14, 49, and 37%). The relative risk of CHD was not found to be associated with these genotypes. These data also were similar among selected subgroups (patients with MIs, those with a low-risk lipoprotein profile for CHD, and those with NIDDM). Neither the number of affected vessels nor Gensini's scores differed among the genotype groups. Our case-control study in Japanese subjects did not show that the PON A/B polymorphism is associated with a risk for CHD.

References (16)

There are more references available in the full text version of this article.

Cited by (121)

  • Genetic variation at Q192R and L55M polymorphisms in PON1

    2016, Environmental Toxicology and Pharmacology
  • Paraoxonase 1 gene (Gln<sup>192</sup>-Arg) polymorphism and the risk of coronary artery disease in type 2 diabetes mellitus

    2012, Egyptian Heart Journal
    Citation Excerpt :

    The molecular basis of this variation and decreased PON1 activity is a polymorphism in the coding region of the gene, resulting in an amino acid substitution glutamine (Gln)/arginine (Arg) in position 192.10,11 Recently, the presence of the (Gln192–Arg) polymorphism in the PON1 gene was reported to be an independent risk factor for CHD in a French Caucasian population and Japanese11 patients with type 2 diabetes and in a North American general population12 but could not be confirmed in Finnish,13 Japanese,14 and Chinese15 CAD patients, mostly without diabetes. To investigate the relationship between PON1 gene polymorphism and the presence, extent and severity of CAD in type 2 DM.

  • Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: A meta-analysis based on 88 case-control studies

    2011, Atherosclerosis
    Citation Excerpt :

    In the figures, areas of squares of individual studies are inversely proportional to the variances of the log ORs, and the horizontal lines represent confidence intervals (CIs). A total of 88 eligible association studies were identified [6,11–97], with 44 genotyping more than one variant (Supplementary Fig. 1). For the Q192R polymorphism, 76 studies were available, including a total of 22,080 cases and 34,937 controls.

  • Serum Paraoxonase (PON1) and its Interactions with HDL: Relationship between PON1 and Oxidative Stress

    2010, The HDL Handbook: Biological Functions and Clinical Implications
View all citing articles on Scopus
View full text